CINIE CINIE
中文 | English | Français | Русский
Home CINIE World Nuclear Fusion Nuclear Application

Search Results

Keyword:68Ga-NYM096

Norroy Bioscience's 68Ga-NYM096 Receives FDA Breakthrough Therapy and Fast Track Designations

Norroy Bioscience's 68Ga-NYM096 Receives FDA Breakthrough Therapy and Fast Track Designations

China-based Norroy Bioscience announced on August 19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy and Fast Track designations to its radiopharmaceutical imaging agent 68Ga-NYM096. The agent is a PET imaging tracer targeting carbonic anhydrase IX (CAIX), intended for imaging clear cell renal cell carcinoma (ccRCC). According to the company, 68Ga-NYM096 is being developed as a non-invasive PET imaging tool to characterize renal masses detected by CT or MRI and to help distinguish clear cell renal cell carcinoma from other non-ccRCC renal lesions. Clear cell renal cell carcinoma is the most common subtype of renal cell carcinoma...

2026-08-21

Reading Ranking

  • 1 UKAEA Invests £45 Million to Build Fusion Supercomputer
  • 2 New Mexico Approves Radioactive Materials Licence for Pacific Fusion
  • 3 US Nuclear Regulatory Commission Delays Review Milestone for Orano Enrichment Plant
  • 4 Radiant Expands Microreactor Facilities to Advance Serial Production
  • 5 Poland's Nuclear Power Program Advances Long-Lead Item Procurement for First Plant
  • 6 Iranian Atomic Energy Organization Official Says Domestically Built Fusion Device Will Be Commissioned
  • 7 Middle East Powers Accelerate Civil Nuclear Energy Strategic Deployment
  • 8 "Nuclea Energy" Acquires Moltex Nuclear Technology Assets
  • 9 U.S. Department of Energy Opens Lux Supercomputer to Aid Fusion Design
  • 10 Zhongke Qingneng Wins Bid for DongSheng Fusion HOPE Device Cryogenic System
  • 11 CNNC Fifth Construction Company Completes Ring Rail Assembly for Jinqimen Unit 1
  • 12 Oklo Partners with U.S. Forged Rings to Reshape Domestic Nuclear Manufacturing
  • 13 Asia's Nuclear Power Expansion: When Will Coal and LNG Demand Shift from "Slower Growth" to "Actual Decline"?
  • 14 ENTRA1 Energy Partners with Sargent & Lundy to Advance SMR Deployment
  • 15 France Releases Ten-Year Nuclear Fusion Energy Development Strategy Roadmap
CINIE

Organizing Committee of the Shenzhen Nuclear Expo

Telephone: +86 10-67808008

+86 10-68808008

Email: info@cinie.net

CINIE

Event Overview Support Services Highlights Archive Contact Us

World Nuclear

China Nuclear Power News World Nuclear Power News Expert Views Nuclear Power Technology

Fusion

China Fusion World Fusion Big Science Facilities ITER Program Business & Capital

Nuclear Application

Medical Scientific Research Environmental Protection Industry Food Agriculture Security
About us | All rights reserved
CINIE All rights reserved 2026 ICP License:京ICP备12027382号-9